NetworkNewsAudio Archive - Page 2 of 41

WednesdayJan 17, 2024 3:00 am

NetworkNewsAudio – Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

Related Press Release Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, recently announced that it anticipates reporting record revenue and operating cashflow for the fourth quarter of 2023. The Company estimates that $2.8 million in cashflow from operating activities was generated for the quarter, compared to a negative cashflow of approximately $1.8 million for the same period a year earlier. With total expected revenue for last year estimated at $26.5 million, Alarum anticipates an increase of approximately 41% compared to the total revenue of 2022. Furthermore, it…

ThursdayJan 11, 2024 8:30 am

NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looks to Supercharge Reach, Impact of GLP-1 Agonists with Proprietary Drug-Delivery Solution

Related Editorial Already proven to be a revolutionary treatment for type 2 diabetes and weight loss, glucagon-like peptide-1 (GLP-1) agonists now appear to have a multitude of potential blockbuster therapeutic uses, according to recent research. Obviously, diabetes remains a primary indication, given the massive global need. However, the impact of this extraordinary molecule extends far beyond type 2 diabetes. The reach of GLP-1 drugs has widened in ways its inventors likely never imagined. Clinical trials are underway testing GLP-1 drugs to treat Alzheimer’s, Parkinson’s, and even drug addiction, plus there are strong indications of therapeutic efficacy in heart disease and…

FridayNov 17, 2023 7:55 am

NetworkNewsAudio – PaxMedica Inc. (NASDAQ: PXMD) Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data

Related Press Release PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, announced the completion of a type-B meeting with the FDA. During the live meeting, the company discussed the positive results of the recent data from its PAX-HAT-301 study of suramin in Stage One Human African Sleeping Sickness caused by Trypanosoma brucei rhodesiense, a rare and fatal parasitic disease if left untreated. To view the original press release, visit https://nnw.fm/CcN9z About PaxMedica Inc. PaxMedica is a forward-looking, clinical-stage biopharmaceutical firm specializing in cutting-edge anti-purinergic drug therapies (“APT”) aimed at addressing a range of challenging neurologic disorders. The company’s comprehensive portfolio encompasses a…

ThursdayNov 02, 2023 8:30 am

NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Impact of Exclusive Drug-Delivery Solution on GLP-1 Drugs

Related Editorial The prestigious New England Journal of Medicine recently published results of a large study of 2,539 adults wherein weight loss of 49 to 52 pounds was a common outcome. With more than 37 million Americans suffering from diabetes, and with obesity at epidemic levels, it’s little wonder that millions of people are singing their praises of the new class of drugs responsible for these outrageously positive outcomes. GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with type 2 diabetes but are also helping treat obesity. Seems everyone is excited…

TuesdayOct 24, 2023 5:00 am

NetworkNewsAudio – Longeveron Announces Positive Top-Line Results for Lomecel-B(TM) in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease

Related Press Release Longeveron Inc. (Nasdaq: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, recently announced positive top-line results from its Phase 2a trial of its investigational product Lomecel-B™ for the treatment of mild Alzheimer’s disease. To view the original press release, visit https://nnw.fm/ckhHp About Longeveron Inc. Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B™ an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone…

FridayOct 13, 2023 8:30 am

NetworkNewsAudio – GEMXX Corp. (GEMZ) Differentiated from Others in Gold Sector by Vertical Integration Strategy

Related Editorial In volatile economic conditions, smart money seeks stability and moves to safe havens. Historically, one of the safest places and most stable spaces during economic uncertainty is gold, a highly liquid asset that preserves and even increases in value over time and carries no credit risk. The precious metal benefits from multiple levers of demand such as gold jewelry, tech/industrial use and a reserve asset as well as a strategic investment. History has shown that gold’s variable demand pressures enhance a portfolio by improving diversification, providing liquidity and delivering long-term returns. Reacting to uncertainties, many gold mining companies, including GEMXX Corp. (OTC: GEMZ)…

TuesdaySep 26, 2023 8:30 am

NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) Strategic Acquisitions Expand Company Footprint, Increase Revenue Stream, Grow Consumer Base

Related Editorial In the business world, one of the cardinal reasons for mergers and acquisitions (M&As) is the potential for synergistic growth. Successful companies usually measure this in terms of revenue streams, market share and product offerings. However, in the age of digital technology and globalization, a significant facet of growth potential is often found a company's core customer base and digital reputation. Lucy Scientific Discovery (NASDAQ: LSDI) (Profile) is astutely following this road map utilized by hugely successful corporations by uniquely leveraging user bases to rapidly amplify shareholder value. This well-established, albeit counterintuitive, M&A strategy has been utilized by…

ThursdayJul 06, 2023 7:50 am

NetworkNewsAudio – Ascendiant Capital Markets Initiates Coverage of Knightscope with Buy Rating and $3.50 Per Share Price Target

Related Press Release Knightscope, Inc. (Nasdaq: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, recently announced that Ascendiant Capital Markets LLC ("Ascendiant") has initiated coverage on the company's stock with a buy rating and a price target of $3.50 per share. To view the original press release, visit https://nnw.fm/E15kA About Knightscope, Inc. Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America…

MondayJun 12, 2023 8:30 am

NetworkNewsAudio – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Awarded $4M Contract from ‘Milestone Company Maker’ Partner

Related Editorial The transition from fossil fuels to electrification has created a huge increase in demand for rare earth oxides and demand is expected to get much larger. Rare earth oxides are irreplaceable elements integral to permanent magnets, critical components in electric vehicles and sustainable power generation equipment, especially windmills. About 90% of all permanent magnets are currently produced in China, which is now considering banning or restricting exports of technology to process and refine rare-earth elements. Beijing is also pondering provisions prohibiting or limiting exports of alloy technology used in making high performance magnets made from rare earths minerals.…

MondayMar 27, 2023 5:30 am

NetworkNewsAudio – Slave Lake Zinc (CSE: SLZ) Identifies Pegmatite, Zinc-Lead-Copper Intersects in Historic Drill Logs

Related Press Release Slave Lake Zinc (CSE: SLZ) (the "Company") has reviewed historic drill logs recently obtained for 13 drill holes reported by American Yellowknife Mines from drilling conducted in 1951 at the MCO targets on the west side of O'Connor Lake. Slave Lake has noted that pegmatites and pegmatitic granites have been documented in these holes. Pegmatites were reported and ranged from less than 1 meter to over 10 meters in drill section. Exploration in 1951 was designed to test for zinc-lead-copper mineralization at O'Connor Lake. There was no evaluation for lithium or tantalum-columbite mineralization which are now a…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsAudio